Compare ITRG & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRG | SOPH |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | Canada | Switzerland |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.9M | 462.3M |
| IPO Year | 2017 | 2021 |
| Metric | ITRG | SOPH |
|---|---|---|
| Price | $2.21 | $5.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.13 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 3.6M | 364.8K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $67.34 | $23.09 |
| Revenue Next Year | $25.89 | $19.57 |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.43 | $2.92 |
| 52 Week High | $4.87 | $6.30 |
| Indicator | ITRG | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 39.78 | 55.54 |
| Support Level | N/A | $4.59 |
| Resistance Level | $2.86 | $5.65 |
| Average True Range (ATR) | 0.14 | 0.40 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 13.00 | 48.89 |
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.